Advisory Research’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-30,220
Closed -$435K – 347
2020
Q1
$435K Sell
30,220
-7,793
-21% -$224K 0.03% 208
2019
Q4
$1.45M Buy
38,013
+7,123
+23% +$213K 0.07% 140
2019
Q3
$683K Buy
+30,890
New +$658K 0.03% 222
2014
Q2
– Sell
-1,563
Closed -$67K – 644
2014
Q1
$67K Buy
+1,563
New +$69K ﹤0.01% 670

Other funds holding THC

Advisory Research's THC Position: Q2 2020 in Review

Advisory Research sold out of Tenet Healthcare (THC) in Q2 2020, closing a stake of 30,220 shares — an estimated $435K sold.

Advisory Research first reported a position in THC in Q1 2014 and held it in 4 quarters. The position peaked at $1.45M in Q4 2019. 239 funds tracked by Wall St. Rank hold THC as of Q2 2020.

  • Advisory Research reported no remaining Tenet Healthcare position as of Q2 2020 after selling out during the quarter.
  • Advisory Research sold 30,220 Tenet Healthcare shares in Q2 2020, an estimated $435K.
  • Advisory Research first reported a position in Tenet Healthcare in Q1 2014 and held it in 4 quarters.
  • Advisory Research's Tenet Healthcare position peaked at $1.45M in Q4 2019.
  • 239 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2020.

Based on Advisory Research's 13F filing for Q2 2020, filed 13 Aug 2020.